LONG-TERM OUTCOMES OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR MACULAR NEOVASCULARIZATION IN PRPH2-ASSOCIATED RETINOPATHY

A favorable long-term outcome can be obtained in PRPH2-associated retinopathy complicated by MNV when timely intravitreal anti-VEGF therapy is administered. Further research is needed to understand the significance of sub-RPE neovascular networks.

Authors

Institutions

Publication Details

Journal
Retina
Published
2025-04-04
DOI
https://doi.org/10.1097/iae.0000000000004476
Citations
1
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
1.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LONG-TERM OUTCOMES OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR MACULAR NEOVASCULARIZATION IN PRPH2-ASSOCIATED RETINOPATHY

Alessandro Arrigo, Rachael C. Heath Jeffery, Isabelle S. Audo, Maurízio Battaglia Parodi et al.
1 citations
Retina
Retinal Diseases and Treatments
1.71
article

LONG-TERM OUTCOMES OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR MACULAR NEOVASCULARIZATION IN PRPH2-ASSOCIATED RETINOPATHY

Alessandro Arrigo, Rachael C. Heath Jeffery, Isabelle S. Audo, Maurízio Battaglia Parodi, Fred K. Chen, Francesco Bandello, Lorenzo Bianco, Christina Zeitz, Ahmad M. Mansour, Alessio Antropoli
article en
1 citations

Abstract

A favorable long-term outcome can be obtained in PRPH2-associated retinopathy complicated by MNV when timely intravitreal anti-VEGF therapy is administered. Further research is needed to understand the significance of sub-RPE neovascular networks.

RetinaVol. 45(8)
Lions Eye Institute (AU), Centre National de la Recherche Scientifique (FR), Institut de la Vision (FR), Vita-Salute San Raffaele University (IT), Inserm (FR), The University of Western Australia (AU), Centre hospitalier national d'ophtalmologie des Quinze-Vingts (FR), Sir Charles Gairdner Hospital (AU), San Raffaele University of Rome (IT), Sorbonne Université (FR), The Royal Victorian Eye & Ear Hospital (AU), Centre for Eye Research Australia (AU), Laboratoire National de Référence (MA), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), American University of Beirut (LB)
Good health and well-being
Openalex Percentile: Top 20%
Retinal Diseases and Treatments
1.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

LONG-TERM OUTCOMES OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR MACULAR NEOVASCULARIZATION IN PRPH2-ASSOCIATED RETINOPATHY — Alessandro Arrigo, Rachael C. Heath Jeffery, et al. · Retina (2025) | TGRS Research Map | TGRS